Senti Biosciences Inc. (SNTI)
3.81
0.00 (0.00%)
At close: Jan 15, 2025, 3:53 PM
Income Statement (Annual)
Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 |
| Revenue | 2.56M | 4.29M | 2.29M | 394.00K | 85.00K |
| Cost of Revenue | 5.24M | 3.92M | 3.01M | 15.96M | 14.52M |
| Gross Profit | -2.68M | 366.00K | -719.00K | -15.56M | -14.44M |
| Operating Income | -92.73M | -70.63M | -40.45M | -24.69M | -21.78M |
| Interest Income | 2.86M | 1.70M | 11.00K | 88.00K | 674.00K |
| Pretax Income | -83.41M | -58.21M | -55.32M | -19.86M | -21.16M |
| Net Income | -92.92M | -58.21M | -55.32M | -19.86M | -21.16M |
| Selling & General & Admin | 34.87M | 40.85M | 21.25M | 9.30M | 7.34M |
| Research & Development | 32.15M | 34.07M | 21.96M | 15.96M | 14.52M |
| Other Expenses | 27.69M | 12.42M | -470.00K | -172.00K | n/a |
| Operating Expenses | 95.29M | 74.92M | 42.74M | 25.09M | 7.39M |
| Interest Expense | n/a | n/a | n/a | n/a | n/a |
| Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a |
| Cost & Expenses | 94.70M | 74.92M | 42.74M | 25.09M | 21.92M |
| Income Tax | n/a | -12.42M | 11.00K | 150.00K | n/a |
| Shares Outstanding (Basic) | 4.44M | 2.61M | 4.37M | 4.37M | 13.59M |
| Shares Outstanding (Diluted) | 4.44M | 2.61M | 4.37M | 4.37M | 13.59M |
| EPS (Basic) | -16.01 | -22.29 | -12.67 | -4.55 | -1.56 |
| EPS (Diluted) | -16.01 | -22.29 | -12.67 | -4.55 | -1.56 |
| EBITDA | -61.34M | -70.63M | -39.68M | -22.71M | -21.36M |
| Depreciation & Amortization | 5.43M | 3.89M | 3.01M | 1.99M | 427.00K |